Cite

    Haidopoulos, D. et al. (n.d.). EP635 Minimizing the dose of oral megestrol in combination with the levonorgestrel-releasing intrauterine device: an equally effective approach for the conservative management of atypical hyperplasia and well differentiated endometrial carcinoma. International journal of gynecological cancer. p. A370. [Online].